Scholarlink

<p>Concomitant immunity (CI) can be viewed as an example of coevolution between the microorganisms and their long-lived hosts. Such an ecological trade-off may be advantageous to both the microbe and the host, as it allows protozoa and helminths to maintain their genetic features while providing the host, particularly mammals, with long-standing protection against reinfection by the same microbe. In <i>Leishmania</i> infection, CI is the mechanism whereby parasites remain at low-level infection in the host, which develops a strong immune reaction that protects against reinfection. Mechanistically, several CD4<sup>+</sup> T cell populations seem to be involved in such fine immune responses. While immunity against <i>Leishmania</i>, <i>Plasmodium</i>, <i>Taenia</i>, <i>Schistosoma</i>, and <i>Echinococcus</i> is well known, the mechanisms of CI involving these pathogens have been poorly studied. Finally, the phenomenon of CI should be carefully assessed in the design of novel vaccine preparations.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Concomitant immunity in persistent Leishmania infections: could it represent an evolutionary balance and a vaccine target?

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月8日

查看全文
  • Francesca Divenuto,
  • Simona Gigliotti,
  • Grazia Pavia,
  • Fabrizio Vitale,
  • Sofia Cortes,
  • Carla Maia,
  • Nadia Marascio,
  • Angela Quirino,
  • Giovanni Matera

摘要

Concomitant immunity (CI) can be viewed as an example of coevolution between the microorganisms and their long-lived hosts. Such an ecological trade-off may be advantageous to both the microbe and the host, as it allows protozoa and helminths to maintain their genetic features while providing the host, particularly mammals, with long-standing protection against reinfection by the same microbe. In Leishmania infection, CI is the mechanism whereby parasites remain at low-level infection in the host, which develops a strong immune reaction that protects against reinfection. Mechanistically, several CD4+ T cell populations seem to be involved in such fine immune responses. While immunity against Leishmania, Plasmodium, Taenia, Schistosoma, and Echinococcus is well known, the mechanisms of CI involving these pathogens have been poorly studied. Finally, the phenomenon of CI should be carefully assessed in the design of novel vaccine preparations.

Graphical Abstract